MDLinx Endocrinology Overview: Our medical editors have ranked and organized papers in the top peer-reviewed clinical journals by topic including diabetes types 1 and 2, thyroid and glandular diseases, obesity and dyslipidemia. In a matter of minutes, you and all the members of your patient care team can stay current on the literature as it is published.
Also on this page: MDLinx exclusive content, including monthly highlights from our physician editor, D. Scott Cunningham, MD, PhD, and clinical pearls from The Smartest Diabetes Expert as well as endocrinology topics in The Smartest Internist, The Smartest Family Physician, and The Smartest Pediatrician daily quiz challenges.
Your Unread Messages in Endocrinology
See All >> Messages include industry-sponsored communications and special communications from MDLinx
D Scott Cunningham MD, PhD
Site Editor, MDLinx
Diabetes is not a risk factor for HCC
Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage
Smartest Doc Challenge
MDLinx
Thyroid Clinical Pearls
MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools
MDLinx Top Read
MDLinx
Running from that pile of unread journals?
341 Percutaneous Ultrasound-Guided Laser Ablation Is Effective for Treating Selected Nodal Metastases in Papillary Thyroid Cancer Journal of Clinical Endocrinology and Metabolism, December 27, 2012
342 The Role of Surgery in the Management of Recurrent Adrenocortical Carcinoma Journal of Clinical Endocrinology and Metabolism, December 27, 2012
343 Preoperative detection and predictors of level V lymph node metastasis in patients with papillary thyroid carcinoma British Journal of Surgery, December 26, 2012
344 Incremental Diagnostic Value of SPECT/CT with 131I Scintigraphy after Radioiodine Therapy in Patients with Well-differentiated Thyroid Carcinoma Radiology, December 26, 2012
345 The association between papillary thyroid carcinoma and histologically-proven Hashimoto's thyroiditis: a meta-analysis European Journal of Endocrinology, December 24, 2012 Evidence Based Medicine
346 Life Expectancy Is Reduced in Differentiated Thyroid Cancer Patients ≥ 45 Years Old with Extensive Local Tumor Invasion, Lateral Lymph Node, or Distant Metastases at Diagnosis and Normal in All Other DTC Patients Journal of Clinical Endocrinology and Metabolism, December 24, 2012
347 Early changes in carcino-embryonic antigen but not in calcitonin levels are correlated with the progression-free survival in medullary thyroid carcinoma patients treated with cytotoxic chemotherapy European Journal of Endocrinology, December 21, 2012
348
A Retrospective Cohort Analysis of the Efficacy of Adjuvant Radiotherapy after Primary Surgical Resection in Patients with Adrenocortical Carcinoma
Journal of Clinical Endocrinology and Metabolism, December 21, 2012
Exclusive Author Commentary
349 The prognostic value of the metastatic lymph node ratio and maximal metastatic tumor size in pathologic N1a papillary thyroid carcinoma European Journal of Endocrinology, December 21, 2012
350 The value of miRNA in diagnosing thyroid cancer: A systematic review Cancer Biomarkers, December 20, 2012 Evidence Based Medicine Clinical Article
351 Effective Perioperative Management of Multiple Endocrine Neoplasia Type 1–Associated Insulinomas JAMA Surgery, December 20, 2012
352 Surgical treatment of neuroendocrine tumors (including carcinoid) Current Opinion in Endocrinology, Diabetes and Obesity, December 19, 2012
353 Significance of MDM2 and P14ARF polymorphisms in susceptibility to differentiated thyroid carcinoma Surgery, December 19, 2012
354 An easy schedule for postsurgical radioiodine administration in newly diagnosed differentiated thyroid carcinoma patients Clinical Endocrinology, December 18, 2012
355 Associations between body mass index and clinico-pathological characteristics of papillary thyroid cancer Clinical Endocrinology, December 18, 2012
356 Integrin {alpha}v{beta}3 Imaging of Radioactive Iodine-Refractory Thyroid Cancer Using 99mTc-3PRGD2 The Journal of Nuclear Medicine, December 18, 2012
357 Malignant pheochromocytoma and paraganglioma: A population level analysis of long-term survival over two decades Journal of Surgical Oncology, December 17, 2012
358 Pituitary Incidentaloma : to Operate or Not to Operate Acta Chirurgica Belgica, December 17, 2012
359 Obesity and Excess Protein and Carbohydrate Consumption Are Risk Factors for Thyroid Cancer Nutrition and Cancer, December 14, 2012
360 Comparative study comparing endoscopic thyroidectomy using the axillary approach and open thyroidectomy for papillary thyroid microcarcinoma World Journal of Surgical Oncology, December 13, 2012
As published in Pancreas, researchers at the Bowman Gray School of Medicine have identified a protein (islet homeostasis protein [IHoP]) which appears to control blood glucose levels by regulating the balance between insulin and glucagon. IHoP is released from glucagon-producing cells in the islets. In both humans and animals, high levels of IHoP exist in the euglycemic state, while T1DM is associated with an absence of IHoP. The authors suggest that IHoP may serve as a target in the treatment of T1DM.
Read the article summaryAs reported in the Archives of Internal Medicine, researchers at the Mayo Clinic have shown an association between statin use and diabetes mellitus in postmenopausal women. The study involved 161,808 postmenopausal women (age range, 50-79 years) who were enrolled at 40 centers between 1993 and 1998 as part of the Women’s Health Initiative. Of the study cohort, data was available for 153,840 women without diabetes at baseline, 7.04% of whom used statins. There were 10,242 incident cases of diabetes in statin users (HR = 1.71) during 1,004,466 person-years of follow-up
Read the article summaryAnthropometric, laboratory, and clinical findings were evaluated in 681 patients with type 2 diabetes mellitus to determine the factors with the greatest influence on determining the basal insulin dosage for a target glucose level < 120 mg/dL. The authors reported that waist circumference, the duration of insulin treatment, lipid-lowering medications, use of insulin sensitizers, the HbA1c, fasting plasma glucose, HDL-C, and triglycerides levels, and severe NAFLD were most significant.
Read the article summary1 Differentiated thyroid carcinoma: defining new paradigms for the post-operative management Endocrine-Related Cancer, April 11, 2013 Review Article
2 Parathyroid Carcinosarcoma: A Rare Parathyroid Carcinoma With Normal Parathyroid Hormone Levels International Journal of Surgical Pathology, April 4, 2013
3 Progress in molecular-based management of differentiated thyroid cancer The Lancet, April 17, 2013
4 Radioactive Iodine in the treatment of Medullary Thyroid Carcinoma: a controlled multicenter study European Journal of Endocrinology, March 7, 2013
5 Selective use of RAI for ablation and adjuvant therapy after total thyroidectomy for differentiated thyroid cancer: A practical approach to clinical decision making Oral Oncology , April 24, 2013
6 Clinical analysis of prophylactic central neck dissection for papillary thyroid carcinoma Clinical and Translational Oncology, April 22, 2013
7 Association between braf v600e mutation and mortality in patients with papillary thyroid cancer JAMA, April 26, 2013
8 Endosonographic and cyst fluid characteristics of cystic pancreatic neuroendocrine tumours: A multicentre case series Digestive and Liver Diseases, April 15, 2013
9 Benefit-Risk Balance of Reoperation for Persistent Medullary Thyroid Cancer Annals of Surgery, April 15, 2013
10 Post-surgical thyroid ablation with low or high radioiodine activities results in similar outcomes in intermediate risk differentiated thyroid cancer patients European Journal of Endocrinology, April 19, 2013 Review Article
11 Comparison of 99mTc-HYNIC-TOC and HYNIC-TATE Octreotide Scintigraphy With FDG PET and 99mTc-MIBI in Local Recurrent or Distant Metastatic Thyroid Cancers Clinical Nuclear Medicine , April 16, 2013 Review Article
12 Protective effect of intraoperative nerve monitoring against recurrent laryngeal nerve injury during re-exploration of the thyroid World Journal of Surgical Oncology, April 25, 2013 Free full text Review Article
13 Evolving Approaches to Patients with Advanced Differentiated Thyroid Cancer Endocrine Reviews, April 11, 2013 Review Article
14 Central lymph node dissection in patients with papillary thyroid cancer: a population level analysis of 14,257 cases The American Journal of Surgery, March 6, 2013 Review Article
15 Urapidil in the Preoperative Treatment of Pheochromocytomas: A Safe and Cost-effective Method World Journal of Surgery, April 10, 2013
16 Lessons learned and questions unanswered from use of multitargeted kinase inhibitors in medullary thyroid cancer Oral Oncology , April 15, 2013 Review Article
17 DNA Microarray and miRNA Analyses Reinforce the Classification of Follicular Thyroid Tumors Journal of Clinical Endocrinology and Metabolism, April 9, 2013 Review Article
18 Variation in the Management of Thyroid Cancer Journal of Clinical Endocrinology and Metabolism, March 29, 2013 Review Article
19 Brain metastases from papillary thyroid carcinomas Virchows Archiv, April 5, 2013
20
The endocrinology of exercise
Internal and Emergency Medicine, March 27, 2013
Review Article
Exclusive Author Commentary
Indexed Journals in Endocrinology: Endocrinology, Journal of Endocrinology, Clinical Endocrinology, Diabetes more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close